Cystic Fibrosis (CF) Completed Phase 2 Trials for Mannitol (DB00742)

Also known as: Mucoviscidosis / Cystic Fibrosis / CF / Fibrosis, Cystic / Cystic fibrosis NOS

IndicationStatusPhase
DBCOND0040212 (Cystic Fibrosis (CF))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01883531Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 YearsTreatment
NCT00117208Comparison of Inhaled Mannitol and rhDNase in Children With Cystic FibrosisTreatment
NCT00251056Mannitol Dose Response Study in Cystic FibrosisTreatment
NCT00455130A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic FibrosisTreatment